Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 3Other hematologic neoplasm 2Lymphoid 2Myeloid 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 413Leukemia 346Leukemia, Myeloid, Acute 289Leukemia, Lymphocytic, Chronic, B-Cell 286Lymphoma 217Myelodysplastic Syndromes 207Lymphoma, Non-Hodgkin 196Burkitt Lymphoma 160Lymphoma, Follicular 149Lymphoma, Mantle-Cell 136Lymphoma, Large B-Cell, Diffuse 135Hodgkin Disease 131Multiple Myeloma 120Lymphoma, B-Cell, Marginal Zone 118Lymphoma, Large-Cell, Immunoblastic 95Leukemia, Myelogenous, Chronic, BCR-ABL Positive 91Hematologic Neoplasms 87Myeloproliferative Disorders 85Leukemia, Myeloid, Chronic-Phase 83Leukemia, Myeloid, Accelerated Phase 80Leukemia, Myelomonocytic, Chronic 78Recurrence 72Congenital Abnormalities 68Blast Crisis 64Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 63Graft vs Host Disease 62Neoplasms, Plasma Cell 61Anemia, Refractory, with Excess of Blasts 60Primary Myelofibrosis 59Dendritic Cell Sarcoma, Interdigitating 59

Interventions

Melphalan 2Cyclophosphamide 2Busulfan 2thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Rituximab 1Levetiracetam 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
beta-Thalassemia × Cyclophosphamide × Other hematologic neoplasm × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡